Filing Details
- Accession Number:
- 0001209191-14-077495
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-22 17:25:33
- Reporting Period:
- 2014-12-18
- Filing Date:
- 2014-12-22
- Accepted Time:
- 2014-12-22 17:25:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1289408 | Keith Valentine | 7475 Lusk Blvd. San Diego CA 92121 | Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-12-18 | 20,000 | $18.31 | 106,471 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-12-18 | 14,107 | $47.70 | 92,364 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-12-19 | 5,893 | $47.78 | 86,471 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-12-18 | 20,000 | $0.00 | 20,000 | $18.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-01-03 | No | 4 | M | Direct |
Footnotes
- Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
- Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on December 12, 2013, which is intended to comply with Rule 10b5-1.
- Weighted average from 18 transactions with prices ranging from $47.5000 to $47.9500. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
- The option, representing a right to purchase a total of 81,534 shares, became exercisable as follows: 25% of the shares vested on January 3, 2007; 1/48th of the remaining shares vested monthly thereafter so that all shares were fully vested as of January 3, 2010, subject to continued employment through each vesting period.
Billionaire Hedge Funds
